搜索优化
English
全部
搜索
图片
视频
地图
资讯
Copilot
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
最佳匹配
最新
资讯
腾讯网
18 小时
FDA再批准礼来阿尔茨海默病药物!
礼来(Eli Lilly and Company)今日宣布,美国FDA已批准Kisunla(donanemab)的标签更新,新增推荐的滴定给药方案。Kisunla为一款每月一次的靶向淀粉样蛋白疗法,适用于早期阿尔茨海默病(AD)患者,包括轻度认知障碍 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Birthright order blocked
Suffers serious injuries
Death ruled a homicide
Tunnel collapses in LA
Sinner defeats Shelton
Hiker dies in Grand Canyon
Six agents suspended
Won't revive immigration law
Utah judge sets execution
Survives confidence vote
US sanctions UN official
Is Outlook down?
Six firefighters injured
Interim NASA administrator
Makes first visit to Asia
Confirmed to lead FAA
Loan interest to restart
Launches Grok 4
Barbie with Type 1 diabetes
Ex-Jazz coach, GM dies
Russian strikes on Kyiv
Copper tariffs to start Aug 1
Unveils AI code of practice
Booker gets max extension
Cases hit highest level
Bitcoin hits record high
Cyclist LeMond honored
To release web browser
US jobless claims fell
Malaysia’s ex-PM turns 100
Court says trial wasn't fair
Ferrero to buy WK Kellogg
反馈